These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33602784)

  • 1. Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors.
    Filippova N; Yang X; Ananthan S; Calano J; Pathak V; Bratton L; Vekariya RH; Zhang S; Ofori E; Hayward EN; Namkoong D; Crossman DK; Crowley MR; King PH; Mobley J; Nabors LB
    Cancer Res; 2021 Apr; 81(8):2220-2233. PubMed ID: 33602784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.
    Wang J; Hjelmeland AB; Nabors LB; King PH
    Cancer Biol Ther; 2019; 20(7):979-988. PubMed ID: 30991885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hu antigen R (HuR) multimerization contributes to glioma disease progression.
    Filippova N; Yang X; Ananthan S; Sorochinsky A; Hackney JR; Gentry Z; Bae S; King P; Nabors LB
    J Biol Chem; 2017 Oct; 292(41):16999-17010. PubMed ID: 28790173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.
    Blanco FF; Preet R; Aguado A; Vishwakarma V; Stevens LE; Vyas A; Padhye S; Xu L; Weir SJ; Anant S; Meisner-Kober N; Brody JR; Dixon DA
    Oncotarget; 2016 Nov; 7(45):74043-74058. PubMed ID: 27677075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HuR biological function involves RRM3-mediated dimerization and RNA binding by all three RRMs.
    Pabis M; Popowicz GM; Stehle R; Fernández-Ramos D; Asami S; Warner L; García-Mauriño SM; Schlundt A; Martínez-Chantar ML; Díaz-Moreno I; Sattler M
    Nucleic Acids Res; 2019 Jan; 47(2):1011-1029. PubMed ID: 30418581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
    Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.
    Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ
    Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.
    Guha A; Waris S; Nabors LB; Filippova N; Gorospe M; Kwan T; King PH
    Adv Drug Deliv Rev; 2022 Feb; 181():114082. PubMed ID: 34923029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation at the disordered N-end makes HuR accumulate and dimerize in the cytoplasm.
    Baños-Jaime B; Corrales-Guerrero L; Pérez-Mejías G; Rejano-Gordillo CM; Velázquez-Campoy A; Martínez-Cruz LA; Martínez-Chantar ML; De la Rosa MA; Díaz-Moreno I
    Nucleic Acids Res; 2024 Aug; 52(14):8552-8565. PubMed ID: 38966993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA-binding protein HuR promotes glioma growth and treatment resistance.
    Filippova N; Yang X; Wang Y; Gillespie GY; Langford C; King PH; Wheeler C; Nabors LB
    Mol Cancer Res; 2011 May; 9(5):648-59. PubMed ID: 21498545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.
    Huang YH; Peng W; Furuuchi N; Gerhart J; Rhodes K; Mukherjee N; Jimbo M; Gonye GE; Brody JR; Getts RC; Sawicki JA
    Cancer Res; 2016 Mar; 76(6):1549-59. PubMed ID: 26921342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.
    Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF
    J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis.
    Palomo-Irigoyen M; Pérez-Andrés E; Iruarrizaga-Lejarreta M; Barreira-Manrique A; Tamayo-Caro M; Vila-Vecilla L; Moreno-Cugnon L; Beitia N; Medrano D; Fernández-Ramos D; Lozano JJ; Okawa S; Lavín JL; Martín-Martín N; Sutherland JD; de Juan VG; Gonzalez-Lopez M; Macías-Cámara N; Mosén-Ansorena D; Laraba L; Hanemann CO; Ercolano E; Parkinson DB; Schultz CW; Araúzo-Bravo MJ; Ascensión AM; Gerovska D; Iribar H; Izeta A; Pytel P; Krastel P; Provenzani A; Seneci P; Carrasco RD; Del Sol A; Martinez-Chantar ML; Barrio R; Serra E; Lazaro C; Flanagan AM; Gorospe M; Ratner N; Aransay AM; Carracedo A; Varela-Rey M; Woodhoo A
    J Clin Invest; 2020 Jul; 130(7):3848-3864. PubMed ID: 32315290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth
    Muralidharan R; Babu A; Amreddy N; Srivastava A; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
    Mol Cancer Ther; 2017 Aug; 16(8):1470-1486. PubMed ID: 28572169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
    Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
    Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional Regulation of
    Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
    Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
    Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
    Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
    PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HuR Affects Proliferation and Apoptosis of Chronic Lymphocytic Leukemia Cells via NF-
    Xiao K; Yang L; Gao X; An Y; Xie W; Jingquan G
    Biomed Res Int; 2020; 2020():1481572. PubMed ID: 32908868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HuR mediates motility of human bone marrow-derived mesenchymal stem cells triggered by sphingosine 1-phosphate in liver fibrosis.
    Chang N; Ge J; Xiu L; Zhao Z; Duan X; Tian L; Xie J; Yang L; Li L
    J Mol Med (Berl); 2017 Jan; 95(1):69-82. PubMed ID: 27543493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.